Skip to main content
. 2020 Dec 1;202(11):1520–1530. doi: 10.1164/rccm.201910-2021OC

Table 2.

Hospital and Treatment Characteristics

  Total Study Population [n (%)]
Propensity-matched Population [n (%)]
  Total Population (N = 53,654) Noninvasive Ventilation (n = 13,540) No Noninvasive Ventilation (n = 40,114) Total Population (n = 25,450) Noninvasive Ventilation (n = 12,725) No Noninvasive Ventilation (n = 12,725)
Hospital beds            
 <200 12,286 (22.9) 2,887 (21.3) 9,399 (23.4) 5,506 (21.3) 2,776 (21.4) 2,730 (21.1)
 200–299 11,599 (21.6) 2,849 (21.0) 8,750 (21.8) 5,493 (21.2) 2,749 (21.2) 2,744 (21.2)
 300–499 15,593 (29.1) 4,219 (31.2) 11,374 (28.4) 7,977 (30.8) 3,997 (30.9) 3,980 (30.8)
 ≥500 14,176 (26.4) 3,585 (26.5) 10,591 (26.4) 6,914 (26.7) 3,423 (26.4) 3,491 (27.0)
Population served            
 Urban 47,765 (89.0) 12,080 (89.2) 35,685 (89.0) 23,130 (89.3) 11,536 (89.1) 11,594 (89.5)
 Rural 5,889 (11.0) 1,460 (10.8) 4,429 (11.0) 2,760 (10.7) 1,409 (10.9) 1,351 (10.4)
Teaching status            
 Teaching 20,358 (37.9) 5,255 (38.8) 15,103 (37.7) 10,176 (39.3) 5,044 (39.0) 5,132 (39.6)
 Nonteaching 33,296 (62.1) 8,285 (61.2) 25,011 (62.4) 15,714 (60.7) 7,901 (61.0) 7,813 (60.4)
Geographic region            
 Midwest 11,590 (21.6) 3,075 (22.7) 8,515 (21.2) 5,909 (22.8) 2,939 (22.7) 2,970 (22.9)
 Northeast 7,747 (14.4) 1,812 (13.4) 5,935 (14.8) 3,537 (13.7) 1,758 (13.6) 1,779 (13.7)
 South 25,525 (47.1) 6,145 (45.4) 19,107 (47.6) 11,714 (45.3) 5,904 (45.6) 5,810 (44.9)
 West 9,065 (16.9) 2,508 (18.5) 6,557 (16.4) 4,730 (18.3) 2,344 (18.1) 2,386 (18.4)
Attending specialty            
 Critical care 903 (1.7) 302 (2.2) 601 (1.5) 585 (2.3) 279 (2.2) 306 (2.4)
 Pulmonology 4,037 (7.5) 1,058 (7.8) 2,979 (7.4) 2,047 (7.9) 1,016 (7.9) 1,031 (8.0)
 Internal medicine 40,473 (75.4) 10,122 (74.8) 30,351 (75.7) 19,333 (74.7) 9,679 (74.8) 9,654 (74.6)
 Family medicine 6,300 (11.7) 1,518 (11.2) 4,782 (11.9) 2,864 (11.1) 1,461 (11.3) 1,403 (10.8)
 Other 1,941 (3.6) 540 (4.0) 1,401 (3.5) 1,615 (4.1) 510 (3.9) 551 (4.3)
Early tests and treatments            
 Short-acting bronchodilators 49,542 (92.3) 12,740 (94.1) 36,802 (91.7) 24,305 (93.9) 12,158 (93.9) 12,147 (93.8)
 Any steroids 50,850 (94.8) 13,091 (96.7) 37,759 (94.1) 25,000 (96.6) 12,502 (96.6) 12,498 (96.6)
 Intravenous steroids 49,200 (91.7) 12,795 (94.5) 36,405 (90.8) 24,388 (94.2) 12,218 (94.4) 12,170 (94.0)
 Oral steroids 10,766 (20.1) 2,527 (18.7) 8,239 (20.5) 4,853 (18.7) 2,417 (18.7) 2,436 (18.8)
 Magnesium 19,808 (36.9) 6,058 (44.7) 13,750 (34.3) 11,582 (44.7) 5,719 (44.2) 5,863 (45.3)
 Inhaled corticosteroid 16,376 (30.5) 4,430 (32.7) 11,946 (29.8) 8,323 (32.2) 4,171 (32.2) 4,152 (32.1)
 Long-acting β2-agonist 10,004 (18.7) 2,713 (20.0) 7,291 (18.2) 5,079 (19.6) 2,542 (19.6) 2,537 (19.6)
 Long-acting antimuscarinic 3,422 (6.4) 1,066 (7.9) 2,365 (5.9) 1,946 (7.5) 970 (7.5) 976 (7.5)
 Leukotriene modifier 14,791 (27.6) 3,934 (29.1) 10,857 (27.1) 7,407 (28.6) 3,705 (28.6) 3,702 (28.6)
 Methylxanthine bronchodilator (theophylline or aminophylline) 2,961 (5.5) 946 (7.0) 2,015 (5.0) 1,737 (6.7) 866 (6.7) 871 (6.7)
 Antibiotics 40,478 (75.4) 10,452 (77.2) 30,026 (74.9) 19,929 (77.0) 9,988 (77.2) 9,941 (76.8)
 Vasopressors 2,043 (3.8) 456 (3.4) 1,587 (4.0) 900 (3.5) 449 (3.5) 451 (3.5)
 Opiates 24,247 (45.2) 6,363 (47.0) 17,884 (44.6) 12,211 (47.2) 6,092 (47.1) 6,119 (47.3)
 Benzodiazepines 23,326 (43.5) 6,568 (48.5) 16,758 (41.8) 12,699 (49.1) 6,301 (48.7) 6,398 (49.4)
 Sputum testing 7,724 (14.4) 1,889 (14.0) 5,835 (14.6) 3,765 (14.5) 1,852 (14.3) 1,913 (14.8)
 Spirometry or peak flow 6,766 (12.6) 1,538 (11.4) 5,228 (13.0) 3,050 (11.8) 1,507 (11.6) 1,543 (11.9)
 Arterial blood gas 33,156 (61.8) 11,398 (84.2) 21,758 (54.2) 21,755 (84.0) 10,824 (83.6) 10,931 (84.4)